Atlas Trials

Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

Clinical trial NCT03088280 · UNKNOWN

Trial details

NCT number
NCT03088280
Sponsor
Hospital Geral de Fortaleza
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Thymoglobulin Dose
Start date
2015-06-30
Primary completion
2018-01-10
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.